Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05718102 · ClinicalTrials.gov registry record · NA
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
A NA study of Pulmonary Disease, Chronic Obstructive, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Recruiting
- Registry status
- NA
- Development phase
- 4,000
- Enrollment target
- 5
- Study locations
NCT05718102 is a NA study of Pulmonary Disease, Chronic Obstructive that is actively recruiting participants, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 4,000 participants, above the 990-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (304% higher). The trial reports 5 study locations across 4 states.
The verdict
NCT05718102, a NA study of Pulmonary Disease, Chronic Obstructive, is actively recruiting participants, sponsored by Seattle Institute for Biomedical and Clinical Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,000 participants
- Enrollment target
- 5
- Study locations
Study Summary
Background: Over 26 million Americans have chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in the United States. Unfortunately, few patients receive proven therapies and many receive therapies known to have safer alternatives. One major reason is the competing demands of primary care providers (PCPs) who manage 90% of patients with COPD. The research team has developed a population management approach where pulmonary specialists provide evidence-based recommendations as an E-consult with unsigned orders to PCPs. PCPs can then quickly review the E-consult and sign, modify, or discontinue these orders. The investigators found this intervention led to marked improvements in the quality-of-care delivered and patients' COPD-related quality-of-life. While promising, this approach is limited by a paucity of pulmonary providers nationwide. Clinical pharmacists are 20 times more prevalent as pulmonary specialists and some regions of VA (VISN 17, COPD Cares) have assigned clinical pharmacists a role in the management of patients with COPD. However, the relative effectiveness of pharmacist-led management is yet to be established. Study Description: This study tests population management for COPD provided by pharmacists relative to pulmonary specialists. The investigators are conducting a cluster randomized clinical trial at five medical centers and their associated clinics within the Department of Veterans Affair. Study staff will randomize PCPs to population management conducted by either pulmonary specialists or pharmacists. Within PCPs' panels, study staff will use VA electronic health record to identify patients with evidence of COPD. Pulmonologists and pharmacists will review these patients and provide guideline-based recommendations to PCPs. Pulmonary specialists and pharmacists will then deliver evidence-based recommendations through E-consults coupled with unsigned orders for primary care providers to sign, modify or decline. O
Conditions Studied
Interventions
- OTHER Population-health management
Study Locations (5)
Washington
- VA Puget Sound Health Care System - Seattle
- Mann-Grandstaff VA Medical Center - Spokane
Minnesota
- Minneapolis VA Health Care System - Minneapolis
Oregon
- Portland VA Medical Center - Portland
South Carolina
- Ralph H. Johnson VA Medical Center - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2027-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05718102
The ClinicalTrials.gov registry entry for NCT05718102 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 990-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (304% higher). The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Population-health management is the first listed.
NCT05718102 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Washington, Minnesota, Oregon.
Frequently Asked Questions
What is clinical trial NCT05718102 about?
NCT05718102 is a clinical study titled "Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD". Background: Over 26 million Americans have chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in the United States. Unfortunately, few patients receive proven therapies and many receive therapies known to have safer alternatives. One major reason is the competing...
What is the current status of trial NCT05718102?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,000 participants. The study started on 2023-05-15. Estimated completion is 2027-01-01.
What conditions does trial NCT05718102 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive.
What interventions are being tested in trial NCT05718102?
The interventions under investigation include: Population-health management (OTHER).
Who is sponsoring clinical trial NCT05718102?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05718102 being conducted?
This trial has 5 study locations across Minnesota, Oregon, South Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Air Filtration for COPD in VA Population of Veterans
ACTIVE NOT RECRUITING · NA
-
Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent
ACTIVE NOT RECRUITING · NA
-
Outlook: An Intervention to Improve Quality of Life in Serious Illness
COMPLETED · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
COMPLETED · NA
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.